What is presbyopia and why does it happen? If you've found yourself needing reading glasses with age, you may have a condition known as presbyopia. "Presbyopia is the age-related decline in the eye's ...
Hosted on MSN
Is it time for reading glasses?
One day the nutrition label on your cereal box is clear as day. The next day the letters and numbers look like an army of fuzzy dots. Presbyopia age-related farsightedness that typically begins around ...
Please provide your email address to receive an email when new articles are posted on . Part one of this series focused on balancing the three interrelated concepts of presbyopia-correcting or visual ...
Yuvezzi is available at retail pharmacies or directly to patients through PHIL, an all-in-one digital hub and ...
Yuvezzi is designed to achieve miosis 30 minutes after one drop for up to 10 hours. The eye drop is available through ...
In its latest webinar, Optician explored the psychological effects of the ageing eye on patients and heard from Bausch + Lomb ...
Optometrist and Johnson & Johnson professional affairs consultant, Faye McDearmid, shares her four steps to successful patient communication about presbyopia ...
Tenpoint Therapeutics, Ltd., a global, commercial biotechnology company focused on developing groundbreaking treatments to improve vision in the aging eye, today announced that the U.S. Food and Drug ...
VIZZ is the first and only aceclidine-based eye drop approved to improve near vision in adults with presbyopia, a condition impacting approximately 128 million adults in the United States First once ...
Tenpoint Therapeutics, a leading ophthalmic manufacturer, and PHIL Inc., an all-in-one digital hub and Direct-to-Patient platform, today announced the launch of a Direct-to-Patient (DTP) cash program ...
– Primary endpoint was met with 71% of participants dosed with LNZ100 achieving three-lines or greater improvement at 3 hours – Rapid onset and long duration shown with 71% of participants achieving ...
Tenpoint Therapeutics, Ltd., a global, commercial biotechnology company focused on developing groundbreaking treatments to improve vision in the aging eye, today announced that the U.S. Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results